# Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

> **NCT00929539** · PHASE2 · COMPLETED · sponsor: **Akros Pharma Inc.** · enrollment: 496 (actual)

## Conditions studied

- Type II Diabetes Mellitus

## Interventions

- **DRUG:** JTT-130
- **DRUG:** JTT-130 Placebo

## Key facts

- **NCT ID:** NCT00929539
- **Lead sponsor:** Akros Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-07
- **Target enrollment:** 496 (ACTUAL)
- **Last updated:** 2013-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929539, "Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00929539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*